Germany-based life sciences service provider Eppendorf is set to begin work on a new production site in Shanghai, China, according to a report from PharmaBiz.com. This expansion marks a significant strategic move for the company, aiming to strengthen its presence in the Chinese market.
New Production Site Details
Eppendorf has signed a contract to begin construction of a new plant at a site in Pinghu, Zhejiang Province. The site is expected to become operational by 2024. This new facility will focus on the manufacturing of centrifuges, aiming to meet the strong local market demand and counter local competitors.
Market Significance and Company Background
Eppendorf reported that it generates around 15% of its global revenues of EUR 1.1 billion (USD 1.18 billion) from the China market, making it a strategic priority for the firm. Eppendorf sells equipment and systems for research laboratories globally, with products including pipettes, mixers, and ultra-low temperature freezers, in addition to centrifuges. The new production site in Shanghai will further enhance Eppendorf’s ability to serve the growing Chinese market and solidify its position as a leading provider of laboratory equipment.-Fineline Info & Tech
